低能量沖擊波治療難治性前列腺盆腔綜合征6個(gè)月療效分析

An analysis of 6-month follow-up efficacy of low-intensity extracorporeal shock wave therapy for refractory prostate-pelvic syndrome

XU Xiao，LI Guizhong，DAI Xiang，WANG Jie

（Department of Urology，Beijing Jishuitan Hospital Affiliated to Capital Medical University，Beijing 100096，China）

ABSTRACT：Objective To evaluate the long-term efficacy and safety of low-intensity extracorporeal shock wave therapy （Li-ESWT） for refractory prostate-pelvic syndrome （PPS）.Methods Clinical data of 173 patients with refractory PPS undergoing Li-ESWT at our hospital during Jan.2020 and Jan.2023 were retrospectively analyzed.All patients received weekly treatment for 8 consecutive weeks.Changes in the National Institutes of Health chronic prostatitis symptom index （NIH-CPSI），international prostate symptom score （IPSS），visual analog scale （VAS），and international index of erectile function-5 （IIEF-5） were compared before treatment，immediately，1，3，and 6 months after treatment.Results A total of 142 patients （82.1%） completed all follow-ups.Compared to baseline data，there was a statistically significant improvement in NIH-CPSI，IPSS，VAS，and IIEF-5 scores immediately after treatment and 1，3，and 6 months after treatment （Plt;0.01）.No significant adverse reactions or complications were observed throughout the follow-up.At the time of treatment completion，115 patients （81.0%） had a decrease of ≥6 in NIH-CPSI; 99 patients （69.7%） had a decrease of ≥3 in IPSS; 121 patients （85.2%） had a decrease of ≥3 in VAS; 105 patients （73.9%） had an increase of ≥4 in IIEF-5.At the 6-month follow-up，patients who responded to treatment maintained satisfactory therapeutic effects.Conclusion Li-ESWT can significantly improve clinical symptoms and quality of life for patients with refractory PPS，with therapeutic effects lasting at least 6 months.

KEY WORDS：low-intensity extracorporeal shock wave therapy; prostate-pelvic syndrome; chronic prostatitis; chronic pelvic pain syndrome

摘要：目的 評(píng)估低能量沖擊波治療難治性前列腺盆腔綜合征的長(zhǎng)期療效及安全性。方法 回顧性分析2020年1月—2023年1月于首都醫(yī)科大學(xué)附屬北京積水潭醫(yī)院泌尿外科接受低能量沖擊波治療的173例難治性前列腺盆腔綜合征患者的臨床資料。所有患者均接受會(huì)陰部低能量沖擊波治療，1次/周，連續(xù)8周。比較患者治療前、治療后當(dāng)時(shí)（療程結(jié)束時(shí)）及治療后1、3、6個(gè)月美國(guó)國(guó)立衛(wèi)生研究院-慢性前列腺炎癥狀指數(shù)（NIH-CPSI）、國(guó)際前列腺癥狀評(píng)分（IPSS）、視覺(jué)疼痛模擬量表評(píng)分（VAS）及國(guó)際勃起功能指數(shù)5評(píng)分（IIEF-5）的變化。結(jié)果 共有142例（82.1%）患者完成全部隨訪。患者治療后當(dāng)時(shí)及治療后1、3、6個(gè)月的NIH-CPSI、IPSS、VAS、IIEF-5均較治療前明顯改善，差異有統(tǒng)計(jì)學(xué)意義（Plt;0.01）。所有患者隨訪全程未見(jiàn)明顯不良反應(yīng)及并發(fā)癥發(fā)生。治療后當(dāng)時(shí)NIH-CPSI下降≥6分的患者有115例（81.0%）；IPSS下降≥3分的患者有99例（69.7%）；VAS下降≥3分的患者有121例（85.2%）；IIEF-5升高≥4分的患者有105例（73.9%）。治療后6個(gè)月時(shí)，上述治療有效的患者均可以維持令人滿意的療效。結(jié)論 采用低能量沖擊波治療難治性前列腺盆腔綜合征，能顯著改善患者的臨床癥狀，提高其生活質(zhì)量，療效至少可維持6個(gè)月。

關(guān)鍵詞：低能量沖擊波；前列腺盆腔綜合征；慢性前列腺炎；慢性骨盆疼痛綜合征

中圖分類號(hào)：R697.3 文獻(xiàn)標(biāo)志碼：ADOI：10.3969/j.issn.1009-8291.2025.02.013

收稿日期：2024-08-04 修回日期：2024-10-31

通信作者：李貴忠，主任醫(yī)師。E-mail：doctorlgz8207@163.com

作者簡(jiǎn)介：徐嘯，博士，副主任醫(yī)師。研究方向：泌尿外科常見(jiàn)疾病的診治、沖擊波在泌尿外科中的應(yīng)用。

E-mail：xuxiao23009@163.com

慢性前列腺炎是50歲以下男性最常見(jiàn)的泌尿系統(tǒng)疾病之一。按……